Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

AIT Therapeutics, Inc. (AITB)

(Delayed Data from OTC)

$5.30 USD

+0.51 (10.65%)

Updated May 3, 2019 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	17.88%
3	Hold	9.47%
4	Sell	5.14%
5	Strong Sell	2.57%
S&P	500	11.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Beyond Air, Inc. [AITB]

Reports for Purchase

Showing records 1 - 20 ( 27 total )

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 1

06/26/2019

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 2

06/26/2019

Pages: 7

FY4Q19 Recap - PMA Submission on Track for CY3Q19

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 3

02/14/2019

Pages: 7

FY3Q19 Recap - Big Year on Tap

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 4

02/14/2019

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 5

01/28/2019

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 6

01/25/2019

Pages: 6

Reiterate Buy as Risk Profile Improves Significantly

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 7

01/03/2019

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 8

01/02/2019

Pages: 4

Reiterate Buy as Partnership Approaches

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 9

11/15/2018

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 10

11/15/2018

Pages: 8

FY2Q19 Recap - PPHN Partnership Could Be Major Catalyst in 2018

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Medical - Drugs

Record: 11

10/23/2018

Pages: 10

ValuEngine Detailed Valuation Report for AITB

Provider: ValuEngine, Inc

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 12

08/15/2018

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 13

08/14/2018

Pages: 7

FY1Q19 Recap - PPHN Filing and Partnership Still the Drivers

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 14

06/19/2018

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 15

06/18/2018

Pages: 7

PPHN Filing and Partnership the Drivers

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 16

06/14/2018

Pages: 4

NO-BRO Results - Program Advances to Pivotal Stage

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 17

06/14/2018

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 18

03/22/2018

Pages: 8

4Q17 Recap - PPHN the Focus

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 19

03/22/2018

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Beyond Air, Inc.

Industry: Unclassified

Record: 20

01/24/2018

Pages: 4

Bacterial Load Data Further Supports Mechanism of Action

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 10.00

Research Provided by a Third Party

previous
1
2
next